DE3280245D1 - Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen. - Google Patents

Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.

Info

Publication number
DE3280245D1
DE3280245D1 DE8282200960T DE3280245T DE3280245D1 DE 3280245 D1 DE3280245 D1 DE 3280245D1 DE 8282200960 T DE8282200960 T DE 8282200960T DE 3280245 T DE3280245 T DE 3280245T DE 3280245 D1 DE3280245 D1 DE 3280245D1
Authority
DE
Germany
Prior art keywords
imidazole compounds
production
pharmaceutical compositions
preparation
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8282200960T
Other languages
English (en)
Inventor
Angelo Carenzi
Dario Chiarino
Bella Davide Della
Viviana Frigeni
Carlo Veneziani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE3280245D1 publication Critical patent/DE3280245D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
DE8282200960T 1981-07-31 1982-07-27 Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen. Expired - Fee Related DE3280245D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23270/81A IT1168008B (it) 1981-07-31 1981-07-31 Imidazol-eteri ed ester, procedimenti per prepararli e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
DE3280245D1 true DE3280245D1 (de) 1990-10-25

Family

ID=11205498

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282200960T Expired - Fee Related DE3280245D1 (de) 1981-07-31 1982-07-27 Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.

Country Status (13)

Country Link
US (1) US4560696A (de)
EP (1) EP0074130B1 (de)
JP (1) JPS5849369A (de)
AT (1) ATE56707T1 (de)
AU (1) AU557494B2 (de)
CA (1) CA1186315A (de)
DE (1) DE3280245D1 (de)
DK (1) DK158944C (de)
ES (1) ES515895A0 (de)
GR (1) GR76886B (de)
IT (1) IT1168008B (de)
PT (1) PT75338B (de)
ZA (1) ZA825428B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206257A (en) * 1987-03-05 1993-04-27 May & Baker Limited Pesticidal method using 2-phenylimidazole derivatives
HUT67475A (en) * 1992-07-20 1995-04-28 Eisai Co Ltd Benzene derivatives and pharmaceutical compositions containing them as active components
US6613789B2 (en) 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
TR200201568T2 (tr) 1999-12-16 2002-10-21 Schering Corporation İkame edilmiş imidazol nöropeptid Y Y5 reseptörü antagonistleri.
ES2159489B1 (es) * 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.
CN102775354A (zh) * 2011-05-10 2012-11-14 无锡立诺康医药科技有限公司 一种合成4-芳基-5-羧酸咪唑及其酯的工艺方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570212A (en) * 1975-10-29 1980-06-25 Smithkline Corp Imidazoles
US4104473A (en) * 1976-04-23 1978-08-01 Shikoku Chemicals Corporation Novel imidazole compounds and process for preparations thereof
US4124766A (en) * 1977-02-03 1978-11-07 American Cyanamid Company Substituted 3-(4-imidazolylmethylene)carbazic and thiocarbazic acid esters
US4139708A (en) * 1977-05-24 1979-02-13 Sk&F Lab Co. Intermediates and processes useful for preparing medicinal agents imidazolemethylphosphonium salts
KR810000359B1 (ko) * 1980-03-31 1981-04-22 한국과학기술원 히드록시메틸이미다졸 화합물의 제조방법

Also Published As

Publication number Publication date
AU557494B2 (en) 1986-12-24
PT75338A (en) 1982-08-01
DK158944B (da) 1990-08-06
DK158944C (da) 1991-01-21
ES8403463A1 (es) 1984-04-01
PT75338B (en) 1985-01-04
ES515895A0 (es) 1984-04-01
DK341882A (da) 1983-02-01
JPH0337549B2 (de) 1991-06-05
EP0074130A3 (en) 1983-08-10
JPS5849369A (ja) 1983-03-23
EP0074130A2 (de) 1983-03-16
ATE56707T1 (de) 1990-10-15
US4560696A (en) 1985-12-24
AU8660582A (en) 1983-02-03
CA1186315A (en) 1985-04-30
IT1168008B (it) 1987-05-20
IT8123270A0 (it) 1981-07-31
EP0074130B1 (de) 1990-09-19
GR76886B (de) 1984-09-04
ZA825428B (en) 1983-08-31

Similar Documents

Publication Publication Date Title
ATE135712T1 (de) Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung
DK162992C (da) Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ES8506705A1 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
AT384424B (de) Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DE3676179D1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
ATE9472T1 (de) Amino-desoxy-1.4; 3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE3280245D1 (de) Imidazolverbindungen, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen.
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE17727T1 (de) Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel.
ATE18226T1 (de) Pyrrolo(2,3-d)carbazolderivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ES8304975A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
ATE9330T1 (de) Phenethanolamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE2794T1 (de) 1-n-alkylsisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3678470D1 (de) Neue 3-pyridylmethylnaphthylderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
SE7906681L (sv) Ftalazonderivat
PT82174A (de) Neue imidazolylverbindungen und verfahren zu ihrer herstellung
ATE118773T1 (de) Verfahren zur herstellung von 2-(3-pyridyl)- tetrahydrothiopyran-2-carbonsäurethioamid-1- (1r,2r)oxyden, die so erhaltenen 2-(3-pyridyl)- tetrahydrothiopyran-2-carbothioamid-1- (1r,2r)oxyde und diese enthaltende pharmazeutische zusammenstellungen.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
ATE23528T1 (de) +/- 2-((3,4-methylenedioxy)phenethyl)-5-((3carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidine, pharmazeutische zusammenstellungen die sie enthalten, verfahren zur herstellung und deren zwischenprodukte.
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee